In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. COVID- 19 Tests are carried out to screen for and detect infections caused by the emerging pathogen, the SARS-CoV-2- coronavirus, which was first identified in China in early 2020. GlobalData uses proprietary data and analytics to provide a comprehensive report on the covid-19 tests market in Canada. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the covid-19 tests market in Canada was F. Hoffmann-La Roche followed by Altona Diagnostic, Hologic, Danaher, bioMerieux, Abbott Laboratories, Becton Dickinson and Co, Qiagen, Revvity, DiaSorin, Quidelortho, Thermo Fisher Scientific and BGI Genomics.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
COVID-19 Tests include COVID-19 Laboratory Tests - Nucleic Acid Amplification Tests (NAATs), COVID-19 Singleplex Nucleic Acid Amplification Tests (NAATs) and, COVID-19 Multiplex Nucleic Acid Amplification Tests (NAATs).
The covid-19 tests market in Canada can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size covid-19 tests in Canada, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.